Legal Representation
Attorney
Olivia M. Clavio
USPTO Deadlines
Next Deadline
2049 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20250805)
Due Date
August 05, 2031
Grace Period Ends
February 05, 2032
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
30 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 5, 2025 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Aug 5, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Aug 5, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 17, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 17, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 11, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 13, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 12, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 12, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 12, 2025 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| May 12, 2025 | RCCK | S | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | Loading... |
| Mar 21, 2025 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Jan 10, 2025 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Dec 25, 2024 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Dec 25, 2024 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Oct 28, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 28, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| Oct 28, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Sep 29, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 29, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 29, 2024 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Apr 23, 2024 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Mar 29, 2024 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Mar 29, 2024 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Mar 10, 2024 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Mar 9, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 9, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 1, 2023 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 28, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 27, 2023 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Ingestible drug delivery agents in the form of capsules filled with pharmaceutical preparations for the treatment of cardiovascular disease, cancerous diseases, joint diseases, infectious diseases, gastrointestinal diseases, ocular disorders and diseases, bacteria-based diseases and disorders, autoimmune diseases and disorders, kidney diseases and disorders, bone diseases, diabetes, blood disorders, pain, inflammation, sepsis, alopecia, obesity, cognitive disorders, respiratory diseases and disorders, and immune system related diseases and disorders
Class 010
Medical apparatus and instruments for use in endovascular procedures; Drug delivery devices sold empty, in the nature of self-implanting endovascular spikes, contained within ingestible dissolvable capsules, for medical, dental or veterinary use; Ingestible devices for use in medical diagnosis and treatment, namely, capsule endoscopes for medical purposes
Class 042
Scientific research for medical purposes; medical laboratory services; consultancy relating to product research and development in the field of ingestible devices; laboratory research services relating to oral delivery devices for pharmaceuticals that cannot be absorbed from an ordinary tablet or capsule; scientific research and product development; research and development of new products; clinical research in the field of pharmaceuticals; biological research and medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific laboratory services
Classification
International Classes
005
010
042